Andrew Subudhi
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude Sickness | 22 | 2025 | 153 | 4.630 |
Why?
| | Cerebrovascular Circulation | 23 | 2017 | 241 | 4.370 |
Why?
| | Acclimatization | 21 | 2025 | 177 | 3.560 |
Why?
| | Hypoxia | 30 | 2024 | 1112 | 3.460 |
Why?
| | Altitude | 31 | 2025 | 485 | 3.410 |
Why?
| | Exercise | 24 | 2025 | 2044 | 2.350 |
Why?
| | Oxygen Consumption | 20 | 2024 | 695 | 2.200 |
Why?
| | Oxygen | 20 | 2023 | 930 | 2.020 |
Why?
| | Middle Cerebral Artery | 7 | 2015 | 53 | 1.550 |
Why?
| | Homeostasis | 7 | 2017 | 619 | 1.550 |
Why?
| | Blood Flow Velocity | 13 | 2017 | 412 | 1.170 |
Why?
| | Hemoglobins | 5 | 2025 | 353 | 1.140 |
Why?
| | Epoetin Alfa | 1 | 2025 | 9 | 0.980 |
Why?
| | Erythropoietin | 1 | 2025 | 95 | 0.890 |
Why?
| | Brain | 8 | 2016 | 2664 | 0.820 |
Why?
| | Iron | 1 | 2025 | 312 | 0.810 |
Why?
| | Carbon Dioxide | 10 | 2015 | 267 | 0.730 |
Why?
| | Methazolamide | 1 | 2020 | 4 | 0.680 |
Why?
| | Arterial Pressure | 3 | 2016 | 126 | 0.670 |
Why?
| | Theophylline | 1 | 2020 | 67 | 0.660 |
Why?
| | Quadriceps Muscle | 4 | 2023 | 132 | 0.640 |
Why?
| | Muscle Fatigue | 6 | 2014 | 102 | 0.640 |
Why?
| | Antioxidants | 6 | 2013 | 584 | 0.630 |
Why?
| | Acute Disease | 9 | 2020 | 1007 | 0.560 |
Why?
| | Physical Endurance | 7 | 2020 | 275 | 0.550 |
Why?
| | Posture | 2 | 2017 | 186 | 0.540 |
Why?
| | Young Adult | 25 | 2025 | 13129 | 0.530 |
Why?
| | Bicycling | 10 | 2011 | 114 | 0.520 |
Why?
| | Adult | 45 | 2025 | 37643 | 0.490 |
Why?
| | Exercise Test | 8 | 2024 | 625 | 0.470 |
Why?
| | Cross-Over Studies | 8 | 2020 | 562 | 0.470 |
Why?
| | Muscle Contraction | 2 | 2007 | 423 | 0.440 |
Why?
| | Spectroscopy, Near-Infrared | 7 | 2020 | 56 | 0.430 |
Why?
| | Regional Blood Flow | 4 | 2013 | 473 | 0.420 |
Why?
| | Radial Artery | 2 | 2013 | 68 | 0.410 |
Why?
| | Male | 46 | 2025 | 67330 | 0.400 |
Why?
| | Ultrasonography, Doppler, Transcranial | 7 | 2013 | 45 | 0.400 |
Why?
| | Acetazolamide | 2 | 2011 | 26 | 0.380 |
Why?
| | Hypoxia, Brain | 2 | 2011 | 8 | 0.380 |
Why?
| | Athletic Performance | 2 | 2012 | 79 | 0.370 |
Why?
| | Oxidative Stress | 6 | 2018 | 1314 | 0.370 |
Why?
| | Humans | 64 | 2025 | 136803 | 0.350 |
Why?
| | Erythrocytes | 4 | 2017 | 699 | 0.350 |
Why?
| | Hyperoxia | 2 | 2010 | 90 | 0.340 |
Why?
| | Blood Pressure | 4 | 2017 | 1774 | 0.330 |
Why?
| | Atmospheric Pressure | 1 | 2010 | 23 | 0.330 |
Why?
| | Double-Blind Method | 9 | 2020 | 1982 | 0.330 |
Why?
| | Dexamethasone | 2 | 2011 | 368 | 0.320 |
Why?
| | Pulmonary Gas Exchange | 4 | 2019 | 121 | 0.300 |
Why?
| | Pulmonary Ventilation | 4 | 2013 | 79 | 0.300 |
Why?
| | Motor Cortex | 1 | 2009 | 65 | 0.290 |
Why?
| | Competitive Behavior | 1 | 2008 | 43 | 0.280 |
Why?
| | Respiratory Mechanics | 1 | 2007 | 67 | 0.270 |
Why?
| | Physical Exertion | 2 | 2007 | 215 | 0.270 |
Why?
| | Muscle, Skeletal | 7 | 2023 | 1710 | 0.260 |
Why?
| | Maximal Voluntary Ventilation | 1 | 2006 | 8 | 0.260 |
Why?
| | Receptor, Adenosine A2B | 2 | 2017 | 43 | 0.260 |
Why?
| | Female | 27 | 2025 | 72816 | 0.260 |
Why?
| | Frontal Lobe | 1 | 2007 | 149 | 0.260 |
Why?
| | Prefrontal Cortex | 1 | 2009 | 304 | 0.240 |
Why?
| | Respiration | 5 | 2012 | 199 | 0.230 |
Why?
| | Ventricular Function, Right | 2 | 2024 | 282 | 0.230 |
Why?
| | Models, Cardiovascular | 3 | 2011 | 195 | 0.220 |
Why?
| | Adaptation, Physiological | 3 | 2016 | 549 | 0.220 |
Why?
| | Cerebral Cortex | 1 | 2007 | 433 | 0.210 |
Why?
| | Sports | 3 | 2012 | 231 | 0.200 |
Why?
| | Single-Blind Method | 5 | 2012 | 282 | 0.200 |
Why?
| | Blood Gas Analysis | 5 | 2015 | 74 | 0.190 |
Why?
| | Vertebral Artery | 2 | 2012 | 26 | 0.190 |
Why?
| | Carotid Artery, Internal | 2 | 2012 | 42 | 0.190 |
Why?
| | Anaerobic Threshold | 3 | 2009 | 28 | 0.190 |
Why?
| | Rest | 4 | 2015 | 121 | 0.190 |
Why?
| | Heart Rate | 5 | 2014 | 820 | 0.180 |
Why?
| | Skiing | 1 | 2001 | 45 | 0.170 |
Why?
| | Time Factors | 9 | 2016 | 6809 | 0.160 |
Why?
| | Proteomics | 2 | 2018 | 1109 | 0.150 |
Why?
| | Adenosine | 2 | 2017 | 225 | 0.150 |
Why?
| | Energy Metabolism | 3 | 2018 | 919 | 0.140 |
Why?
| | Metabolome | 2 | 2018 | 350 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 17 | 0.130 |
Why?
| | Inhalation | 2 | 2007 | 29 | 0.130 |
Why?
| | Sphingosine | 1 | 2016 | 46 | 0.130 |
Why?
| | Lysophospholipids | 1 | 2016 | 80 | 0.120 |
Why?
| | Syncope | 1 | 2016 | 52 | 0.120 |
Why?
| | Foramen Ovale, Patent | 1 | 2015 | 10 | 0.120 |
Why?
| | Carotid Arteries | 1 | 2016 | 206 | 0.120 |
Why?
| | Severity of Illness Index | 3 | 2013 | 2822 | 0.110 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2016 | 197 | 0.110 |
Why?
| | Tibet | 1 | 2014 | 27 | 0.110 |
Why?
| | Erythropoiesis | 1 | 2014 | 55 | 0.110 |
Why?
| | Peru | 1 | 2014 | 58 | 0.110 |
Why?
| | Bolivia | 1 | 2014 | 65 | 0.110 |
Why?
| | Glutathione | 3 | 2016 | 356 | 0.110 |
Why?
| | Mountaineering | 2 | 2011 | 40 | 0.100 |
Why?
| | Lipid Peroxidation | 2 | 2004 | 153 | 0.100 |
Why?
| | Carotid Artery, External | 1 | 2012 | 3 | 0.100 |
Why?
| | Surveys and Questionnaires | 5 | 2013 | 5744 | 0.100 |
Why?
| | Healthy Volunteers | 3 | 2018 | 199 | 0.100 |
Why?
| | Analysis of Variance | 4 | 2010 | 1316 | 0.090 |
Why?
| | Malondialdehyde | 2 | 2009 | 29 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2023 | 1905 | 0.090 |
Why?
| | Blood Proteins | 1 | 2013 | 252 | 0.090 |
Why?
| | Skull | 1 | 2012 | 139 | 0.090 |
Why?
| | Motor Activity | 2 | 2014 | 717 | 0.090 |
Why?
| | Pulse Wave Analysis | 1 | 2012 | 269 | 0.090 |
Why?
| | Pulmonary Edema | 2 | 2010 | 107 | 0.090 |
Why?
| | Vasoconstriction | 1 | 2012 | 202 | 0.090 |
Why?
| | Body Temperature Regulation | 1 | 2012 | 97 | 0.090 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 78 | 0.090 |
Why?
| | Glycolysis | 3 | 2018 | 319 | 0.090 |
Why?
| | Cold Temperature | 1 | 2012 | 178 | 0.090 |
Why?
| | Lactic Acid | 3 | 2009 | 305 | 0.090 |
Why?
| | Cerebral Arteries | 1 | 2011 | 59 | 0.090 |
Why?
| | Forecasting | 1 | 2012 | 388 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 2018 | 1059 | 0.080 |
Why?
| | Running | 1 | 2012 | 230 | 0.080 |
Why?
| | Fourier Analysis | 1 | 2009 | 40 | 0.080 |
Why?
| | Ribose | 1 | 2009 | 23 | 0.080 |
Why?
| | Hot Temperature | 1 | 2012 | 391 | 0.080 |
Why?
| | Vasodilation | 1 | 2012 | 496 | 0.080 |
Why?
| | Manometry | 1 | 2009 | 95 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2012 | 350 | 0.080 |
Why?
| | Reaction Time | 1 | 2011 | 412 | 0.080 |
Why?
| | Anticonvulsants | 1 | 2011 | 215 | 0.080 |
Why?
| | Algorithms | 3 | 2014 | 1690 | 0.070 |
Why?
| | Heart Ventricles | 2 | 2024 | 785 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1758 | 0.070 |
Why?
| | Exhalation | 1 | 2007 | 39 | 0.070 |
Why?
| | Oxyhemoglobins | 1 | 2007 | 23 | 0.070 |
Why?
| | Pentose Phosphate Pathway | 2 | 2018 | 53 | 0.070 |
Why?
| | Nutritional Requirements | 1 | 2007 | 78 | 0.070 |
Why?
| | Blood Volume | 1 | 2007 | 61 | 0.070 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 41 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 2 | 2016 | 32 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 72 | 0.060 |
Why?
| | Predictive Value of Tests | 2 | 2009 | 2022 | 0.060 |
Why?
| | Sports Medicine | 1 | 2008 | 112 | 0.060 |
Why?
| | Cognition | 1 | 2014 | 1146 | 0.060 |
Why?
| | Drinking | 1 | 2005 | 42 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2013 | 597 | 0.060 |
Why?
| | Recovery of Function | 1 | 2009 | 652 | 0.060 |
Why?
| | Feeding and Eating Disorders | 1 | 2007 | 152 | 0.060 |
Why?
| | Physical Education and Training | 1 | 2004 | 76 | 0.060 |
Why?
| | Placebos | 1 | 2004 | 199 | 0.060 |
Why?
| | Reproducibility of Results | 3 | 2007 | 3265 | 0.050 |
Why?
| | Lung | 2 | 2015 | 4063 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2006 | 279 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2006 | 408 | 0.050 |
Why?
| | Partial Pressure | 2 | 2013 | 30 | 0.050 |
Why?
| | Hypercapnia | 2 | 2013 | 53 | 0.050 |
Why?
| | Respiratory Function Tests | 1 | 2004 | 595 | 0.050 |
Why?
| | DNA Damage | 1 | 2004 | 420 | 0.050 |
Why?
| | Adolescent | 3 | 2017 | 21385 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 778 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2017 | 5750 | 0.050 |
Why?
| | Chronic Disease | 1 | 2007 | 1786 | 0.050 |
Why?
| | Cardiovascular Diseases | 1 | 2014 | 2105 | 0.040 |
Why?
| | Colorimetry | 1 | 2001 | 12 | 0.040 |
Why?
| | Carbonic Anhydrase Inhibitors | 2 | 2011 | 14 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1242 | 0.040 |
Why?
| | Tidal Volume | 2 | 2012 | 86 | 0.040 |
Why?
| | Brain Edema | 2 | 2011 | 61 | 0.040 |
Why?
| | Bone Density | 1 | 2004 | 487 | 0.040 |
Why?
| | Inflammation | 1 | 2011 | 2835 | 0.040 |
Why?
| | Mice, Knockout | 2 | 2017 | 3009 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2011 | 10748 | 0.040 |
Why?
| | Dehydration | 2 | 2012 | 51 | 0.040 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.040 |
Why?
| | Carnitine | 1 | 2018 | 84 | 0.030 |
Why?
| | Proteolysis | 1 | 2018 | 177 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 353 | 0.030 |
Why?
| | Bisphosphoglycerate Mutase | 1 | 2016 | 7 | 0.030 |
Why?
| | Muscles | 1 | 2018 | 325 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 102 | 0.030 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 16 | 0.030 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 116 | 0.030 |
Why?
| | Diet | 1 | 2004 | 1274 | 0.030 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 45 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 228 | 0.030 |
Why?
| | Sulfur | 1 | 2016 | 58 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 135 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 298 | 0.030 |
Why?
| | Animals | 5 | 2017 | 36850 | 0.030 |
Why?
| | Intracranial Pressure | 1 | 2015 | 47 | 0.030 |
Why?
| | Purines | 1 | 2016 | 176 | 0.030 |
Why?
| | Biomarkers | 3 | 2013 | 4145 | 0.030 |
Why?
| | Arginine | 1 | 2016 | 271 | 0.030 |
Why?
| | Fatty Acids | 1 | 2018 | 442 | 0.030 |
Why?
| | Proteins | 1 | 2001 | 1009 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2016 | 810 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2018 | 441 | 0.030 |
Why?
| | Amino Acids | 1 | 2018 | 497 | 0.030 |
Why?
| | Heart Sounds | 1 | 2014 | 2 | 0.030 |
Why?
| | Heart Auscultation | 1 | 2014 | 3 | 0.030 |
Why?
| | Acid-Base Equilibrium | 1 | 2013 | 28 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 465 | 0.030 |
Why?
| | Chemoreceptor Cells | 1 | 2013 | 51 | 0.030 |
Why?
| | Markov Chains | 1 | 2014 | 123 | 0.030 |
Why?
| | Enzymes | 1 | 2013 | 67 | 0.030 |
Why?
| | Acute Lung Injury | 1 | 2016 | 287 | 0.030 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 2014 | 143 | 0.030 |
Why?
| | Cold Climate | 1 | 2012 | 7 | 0.020 |
Why?
| | Validation Studies as Topic | 1 | 2012 | 22 | 0.020 |
Why?
| | Hypocapnia | 1 | 2012 | 8 | 0.020 |
Why?
| | Risk Factors | 3 | 2012 | 10332 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2013 | 560 | 0.020 |
Why?
| | Myocardial Contraction | 1 | 2014 | 339 | 0.020 |
Why?
| | Frostbite | 1 | 2012 | 21 | 0.020 |
Why?
| | Hypothermia | 1 | 2012 | 36 | 0.020 |
Why?
| | Case-Control Studies | 2 | 2013 | 3540 | 0.020 |
Why?
| | Health Facilities | 1 | 2012 | 83 | 0.020 |
Why?
| | Respiration Disorders | 1 | 2012 | 77 | 0.020 |
Why?
| | Body Composition | 2 | 2006 | 679 | 0.020 |
Why?
| | Heat Stress Disorders | 1 | 2012 | 75 | 0.020 |
Why?
| | Blood Circulation Time | 1 | 2010 | 2 | 0.020 |
Why?
| | Constriction | 1 | 2010 | 47 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 532 | 0.020 |
Why?
| | Vasomotor System | 1 | 2010 | 47 | 0.020 |
Why?
| | Headache | 1 | 2011 | 147 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 138 | 0.020 |
Why?
| | Electrocardiography | 1 | 2012 | 629 | 0.020 |
Why?
| | Mice | 2 | 2017 | 17759 | 0.020 |
Why?
| | Pulse | 1 | 2009 | 23 | 0.020 |
Why?
| | Free Radicals | 1 | 2009 | 110 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2014 | 1936 | 0.020 |
Why?
| | Ventilators, Mechanical | 1 | 2009 | 58 | 0.020 |
Why?
| | Software | 1 | 2014 | 665 | 0.020 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2010 | 157 | 0.020 |
Why?
| | Dietary Carbohydrates | 1 | 2009 | 155 | 0.020 |
Why?
| | Cardiac Output | 1 | 2008 | 164 | 0.020 |
Why?
| | Epinephrine | 1 | 2008 | 139 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 496 | 0.020 |
Why?
| | Norepinephrine | 1 | 2008 | 204 | 0.020 |
Why?
| | Self Disclosure | 1 | 2007 | 63 | 0.020 |
Why?
| | Magnetics | 1 | 2007 | 48 | 0.020 |
Why?
| | Lactates | 1 | 2007 | 85 | 0.020 |
Why?
| | Dogs | 1 | 2008 | 411 | 0.020 |
Why?
| | Sleep | 1 | 2012 | 753 | 0.020 |
Why?
| | Catecholamines | 1 | 2006 | 98 | 0.020 |
Why?
| | Urinalysis | 1 | 2005 | 77 | 0.020 |
Why?
| | Oximetry | 1 | 2005 | 96 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 2004 | 10 | 0.010 |
Why?
| | Maximal Expiratory Flow Rate | 1 | 2004 | 3 | 0.010 |
Why?
| | Middle Aged | 2 | 2020 | 33239 | 0.010 |
Why?
| | Dietary Supplements | 1 | 2009 | 559 | 0.010 |
Why?
| | Models, Biological | 1 | 2012 | 1773 | 0.010 |
Why?
| | Electromyography | 1 | 2007 | 401 | 0.010 |
Why?
| | Anthropometry | 1 | 2004 | 213 | 0.010 |
Why?
| | Pilot Projects | 1 | 2009 | 1693 | 0.010 |
Why?
| | Equipment Design | 1 | 2005 | 521 | 0.010 |
Why?
| | Task Performance and Analysis | 1 | 2004 | 183 | 0.010 |
Why?
| | Signal Transduction | 1 | 2017 | 5077 | 0.010 |
Why?
| | Administration, Oral | 1 | 2005 | 813 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 846 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 484 | 0.010 |
Why?
| | Clinical Protocols | 1 | 2004 | 267 | 0.010 |
Why?
| | Body Weight | 1 | 2005 | 985 | 0.010 |
Why?
| | Data Collection | 1 | 2004 | 668 | 0.010 |
Why?
| | Prevalence | 1 | 2007 | 2710 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2007 | 1322 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2008 | 4282 | 0.010 |
Why?
| | Child | 1 | 2014 | 21819 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 7573 | 0.010 |
Why?
| | United States | 1 | 2004 | 14691 | 0.000 |
Why?
|
|
Subudhi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|